Elevated [18F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease
暂无分享,去创建一个
Albert Gjedde | Paul Cumming | Andreas Heinz | Peter Bartenstein | Ingo Vernaleken | Gerhard Gründer | Yoshitaka Kumakura | E. H. Danielsen | Hans Georg Buchholz | A. Heinz | A. Gjedde | P. Cumming | H. Buchholz | G. Gründer | I. Vernaleken | Y. Kumakura | E. Danielsen | P. Bartenstein
[1] Alan C. Evans,et al. Dopa decarboxylase activity of the living human brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] C. Patlak,et al. Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.
[3] S. Lightman,et al. A Functional Subset of Serotonergic Neurons in the Rat Ventrolateral Periaqueductal Gray Implicated in the Inhibition of Sympathoexcitation and Panic , 2004, Annals of the New York Academy of Sciences.
[4] A. Gjedde,et al. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms , 1998, Synapse.
[5] Claude Nahmias,et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study , 2003, Annals of neurology.
[6] Karl Herholz,et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. , 2005, Archives of neurology.
[7] D J Brooks,et al. Clinical and [18F] dopa PET findings in early Parkinson's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[8] D. Grosset,et al. Problematic gambling on dopamine agonists: Not such a rarity , 2006, Movement disorders : official journal of the Movement Disorder Society.
[9] P. Cumming,et al. Kinetics of the metabolism of four PET radioligands in living minipigs. , 2001, Nuclear medicine and biology.
[10] H. Ruottinen,et al. [(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease. , 2001, Synapse.
[11] R. Pobbe,et al. 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. , 2005, Psychopharmacology.
[12] Hans-Georg Buchholz,et al. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge , 2006, NeuroImage.
[13] Paul Cumming,et al. Net influx of plasma 6‐[18F]fluoro‐l‐DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli , 2006, The European journal of neuroscience.
[14] V Sossi,et al. A Reversible Tracer Analysis Approach to the Study of Effective Dopamine Turnover , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] D. Doudet,et al. Loss of metabolites from monkey striatum during PET with FDOPA , 2001, Synapse.
[16] David P. Chynoweth,et al. Kinetics and modeling. , 1987 .
[17] L. Descarries,et al. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. , 1994, The Journal of pharmacology and experimental therapeutics.
[18] R. Pobbe,et al. 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus , 2005, Psychopharmacology.
[19] Paul Cumming,et al. Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study , 2007, Neurobiology of Aging.
[20] Y. Wang,et al. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT1A receptor stimulation in the rat , 2009, Neuroscience.
[21] Scott T. Grafton,et al. Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Daniel Weintraub,et al. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease , 2007, Nature Clinical Practice Neurology.
[23] Janneke Koerts,et al. Striatal dopaminergic activity (FDOPA‐PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease , 2007, The European journal of neuroscience.
[24] Valtteri Kaasinen,et al. Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. , 2008, Parkinsonism & related disorders.
[25] Gislaine Garcia Pelosi,et al. Cardiovascular effects of noradrenaline microinjected into the dorsal periaqueductal gray area of unanaesthetized rats , 2005, The European journal of neuroscience.
[26] Alan C. Evans,et al. Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] V Sossi,et al. Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] D. Brooks,et al. Extrastriatal monoamine neuron function in Parkinson’s disease: An 18F-dopa PET study , 2008, Neurobiology of Disease.
[29] Albert Gjedde,et al. PET Studies of Net Blood—Brain Clearance of FDOPA to Human Brain: Age-Dependent Decline of [18F]Fluorodopamine Storage Capacity , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] P. Clarke,et al. Segregation of Amphetamine Reward and Locomotor Stimulation between Nucleus Accumbens Medial Shell and Core , 2003, The Journal of Neuroscience.
[31] Alan A. Wilson,et al. Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease , 2007, European journal of neurology.
[32] K Wienhard,et al. Functional effects of striatal dysfunction in Parkinson disease. , 1997, Archives of neurology.
[33] Paul Cumming,et al. Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease. , 2005, Archives of neurology.
[34] A. Gjedde,et al. A Kinetic Analysis of 6‐[18F]Fluoro‐l‐Dihydroxyphenylalanine Metabolism in the Rat , 1994, Journal of neurochemistry.
[35] W D Heiss,et al. Increased pineal Fdopa uptake is related to severity of Parkinson's disease – A PET study , 2001, Journal of pineal research.
[36] Paul Cumming,et al. PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[37] Juan A Flores,et al. Role for Dopamine Neurons of the Rostral Linear Nucleus and Periaqueductal Gray in the Rewarding and Sensitizing Properties of Heroin , 2006, Neuropsychopharmacology.
[38] Karl J. Friston,et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.
[39] Albert Gjedde,et al. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examination , 1982, Brain Research Reviews.
[40] Paul Cumming,et al. Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study , 2007, The Journal of Neuroscience.
[41] Doris J. Doudet,et al. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: A multi-tracer PET study , 2006, NeuroImage.
[42] John Mitrofanis,et al. Patterns of FOS Expression in the Spinal Cord and Periaqueductal Grey Matter of 6OHDA-Lesioned Rats , 2008, The International journal of neuroscience.
[43] Joseph H Friedman,et al. Levodopa addiction in idiopathic Parkinson disease , 2005, Neurology.
[44] A. Gjedde,et al. Pharmacokinetics of Plasma 6-[18F]Fluoro-l-3,4-Dihydroxyphenylalanine ([18F]FDOPA) in Humans , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] Yasin Temel,et al. Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats , 2008, Brain Research.
[47] V Kaasinen,et al. Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. , 2001, Brain : a journal of neurology.
[48] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] Olli Eskola,et al. [18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease , 2001 .
[50] David J. Brooks,et al. Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study , 2003, Brain Research.
[51] Albert Gjedde,et al. Dopamine Storage Capacity in Caudate and Putamen of Patients with Early Parkinson's Disease: Correlation with Asymmetry of Motor Symptoms , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] Jian Liu,et al. Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease. , 2007, Sheng li xue bao : [Acta physiologica Sinica].
[53] Andrew D. Roberts,et al. FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa , 1999, Neurology.
[54] R. Arai,et al. Immunohistochemical detection of l-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats , 2007, Neuroscience Research.
[55] Paul Cumming,et al. The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat , 1997, Brain Research.
[56] Juha O. Rinne,et al. Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease , 2005, Neurobiology of Aging.
[57] G Blomqvist,et al. Kinetic analysis. , 1991, Wiener klinische Wochenschrift.
[58] A Reilhac,et al. Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease , 2004, Acta neurologica Scandinavica.